PREDICT THE FUTURE HEALTH RISK OF YOUR PATIENTS WITHOUT BIOMETRICAL PARAMETERS

We help our partners and clients take advantage

of their unused data to understand individual risks and costs of patients

1

Organizing data so it can be used. (TOOLBOX/ROOM)

2

Showing where the money is going and why it’s going there

3

Predicting which patients will develop future chronic pathologies and when. Also classifying them in risk groups

Our software adapts to the priorities of each business, while being GDPR, HIPAA and MDR compliant

PERSONAL HEALTH SCORE

PREDICTION OF FUTURE RISK

CLASSIFICATION OF PATIENT GROUPS

INTEGRATION WITH TAILORED BUSINESS KPIs

GRAPHIC AND INTUITIVE VISUALIZATION

HOW DO WE DO IT?




NO biometrical parameters


We only use variables that you already have in your database and we do it anonymously. GDPR and HIPAA compliant




Attract more clients with differential value


Patients will get a better service through a personalized risk assessment




Save costs improving margins


Understand expenditure and its link to different patient groups to generate strategies for improvement




Cost-effective


Quality and personalization of expensive consultancy at the price of a standard solution

PRISKY offers a practical analysis of pre-existing data in order to predict the risk of future pathology and optimize the investment of resources

Email

Phone

Message

THE TEAM

This product has been developed by the Medicsen team, a company that has more than 20 professionals with experience in software development, health care and strategic consulting. A team that has always successfully met its business commitments and has been awarded internationally for its technology and business practices

Eduardo
Jorgensen

CEO & Founder

César
de Mercado

COO & Founder

José Carlos
Montesinos

CTO & Founder

Patricia
Cremades

CSO & Founder

Antonio
Reche

Head of Data

Enrique
Mayo

Senior SW Developer

CLIENTS AND PILOTS

ACKNOWLEDGEMENT

PRESS

This site uses cookies to obtain navigation statistical data from users. By continuing to use the site, we consider that you are accepting its use. More information [X Close]